Cancer therapies have made a great deal of progress in recent years, but access to this progress is at risk. Cancer patients are often told that treatments giving them a few more weeks aren’t worth it? But increasingly, living even two weeks longer can mean a fuller and even longer life. New medicines that target specific tumors not only improve well-being, they give people the chance to try a series of new treatments that can allow people to become cancer free.
Reel Innovation Video Series
Accelerated Access to New Treatments a “Moral Imperative” Says John Morrissey of the Schulze Family Foundation
In a powerful and thought-provoking editorial recently published on The Hill, John Morrissey – the Chair of the Scientific Advisory Board of the Richard M. Schulze Family Foundation – deemed the accel…More
The German Breast Group (GBG) said ABRAXANE (nab-paclitaxel) demonstrated significant benefit for patients with early high risk breast cancer when compared to conventional chemotherapy (solvent-based …More
The Center for Medicine in the Public Interest (CMPI) joined with Scientific American Worldview to recognize Worldview’s Top Medical Innovators, four scientists whose work has transformed the diagnosi…More